[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4203 Introduced in Senate (IS)]
<DOC>
117th CONGRESS
2d Session
S. 4203
To extend the National Alzheimer's Project.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
May 12, 2022
Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, Mr.
Moran, and Mr. Menendez) introduced the following bill; which was read
twice and referred to the Committee on Health, Education, Labor, and
Pensions
_______________________________________________________________________
A BILL
To extend the National Alzheimer's Project.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``NAPA Reauthorization Act''.
SEC. 2. EXTENSION OF PROJECT.
Section 2 of the National Alzheimer's Project Act (42 U.S.C. 11225)
is amended--
(1) in subsection (c)--
(A) in paragraph (2), by striking ``and
coordination of'' and inserting ``on, and coordination
of,'';
(B) in paragraph (4)--
(i) by redesignating subparagraphs (A) and
(B) as subparagraphs (B) and (C), respectively;
and
(ii) by inserting before subparagraph (B),
as so redesignated, the following:
``(A) promotion of healthy aging and reduction of
risk factors for Alzheimer's disease;'';
(C) in paragraph (5), by striking ``; and'' and
inserting a semicolon;
(D) by redesignating paragraph (6) as paragraph
(7); and
(E) by inserting after paragraph (5) the following:
``(6) provide information on, and promote the adoption of,
healthy behaviors that may reduce the risk of cognitive decline
and promote and protect cognitive health; and'';
(2) in subsection (d)(2)--
(A) by inserting ``, across public and private
sectors,'' after ``Nation's progress''; and
(B) by inserting ``, including consideration of
public-private collaborations, as appropriate'' before
the period;
(3) in subsection (e)--
(A) in paragraph (2)--
(i) in subparagraph (A), by adding at the
end the following:
``(xi) A designee of the Department of
Justice.
``(xii) A designee of the Federal Emergency
Management Agency.
``(xiii) A designee of the Social Security
Administration.
``(xiv) A designee of the Office of
Management and Budget.''; and
(ii) in subparagraph (B)--
(I) in clause (v)--
(aa) by striking ``2
researchers'' and inserting ``3
researchers''; and
(bb) by striking ``; and''
and inserting ``, including at
least one researcher with
demonstrated experience in
recruitment and retention of
diverse cohorts of trial
participants;'';
(II) in clause (vi), by striking
the period and inserting ``; and''; and
(III) by adding at the end the
following:
``(vii) an individual with a diagnosis of
Alzheimer's disease.'';
(B) in paragraph (5)--
(i) in subparagraph (A)--
(I) by striking ``an initial
evaluation'' and inserting ``annual
evaluations''; and
(II) by striking ``research,
clinical'' and inserting ``research,
risk reduction, public health,
clinical'';
(ii) in subparagraph (B), by striking
``initial'';
(iii) in subparagraph (C)--
(I) in the matter preceding clause
(i), by striking ``initial''; and
(II) in clause (ii), by inserting
``and reduce disparities'' before the
semicolon; and
(iv) in subparagraph (D), by striking
``annually thereafter, an evaluation'' and
inserting ``annual evaluations''; and
(C) in paragraph (6), by striking ``2025'' and
inserting ``2035'';
(4) in subsection (g)(3)(A)(ii), by inserting ``and reduce
disparities'' before the semicolon; and
(5) in subsection (h), by striking ``2025'' and inserting
``2035''.
<all>